Cardio-Oncology Spotlight: BTK Inhibitors and the Heart

The Cardio-Oncology Program at Penn MedicineПодробнее

Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity? Dr. Lili ZhangПодробнее

Cardio-Oncology Spotlight: Risk Stratification with Dr. Anne BlaesПодробнее

Cardio-Oncology Spotlight: Managing Bleeding During BTK TherapyПодробнее

The role of the cardio-oncologist in the treatment of patients with hematological malignanciesПодробнее

Cardio-OncologyПодробнее

Fine What is Cardio-OncologyПодробнее

Cardio-Oncology: Understanding the Connections Between Heart Disease and CancerПодробнее

Overview of the role of non-covalent BTK inhibitors in the era of covalent BTK inhibitorsПодробнее

Cardio-Oncology: Cancer-Therapeutics Related Cardiac DysfunctionПодробнее

Cardio-Oncology Spotlight: Toxicities in Breast Cancer Therapy, Dr. Paul CottuПодробнее

Why is cardio-oncology important?Подробнее

Understanding Cardiotoxicity Risk with BTK Inhibitors in Hematologic Cancers: Muhammad Salman FaisalПодробнее

What is Cardio-Oncology?Подробнее

Cardio-Oncology ClinicПодробнее

JACC: CardioOncology Video Case Presentation: Cardiotoxicity During HER2-Targeted TherapyПодробнее

Cardio Oncology Clinical PearlПодробнее